U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285174) titled 'Shanghai Lymphoma Clinical Cohort' on Dec. 03.
Brief Summary: The aim of this study is to prospectively collect clinical information on patients with lymphoma, and to explore the best therapeutic strategies in the real-world population.
Study Start Date: Dec. 18
Study Type: OBSERVATIONAL
Condition:
Lymphoma
Cohort
Intervention:
OTHER: No interventions need to be specified for this study
No interventions need to be specified for this study
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ruijin Hospital
Information provided by (Responsible Party): Zhao Weili, Ruijin Hospital
Published by HT Digital Content Services with per...